Company intelligence / Profile preview

Pharmel

Istanbul, Istanbul, Turkey

Ownership: Private
Development stage: Other

Overview

Pharmel is a pharmaceutical company focused on the development, manufacturing, and commercialization of a wide range of generic and branded pharmaceutical products. The company operates primarily in the Middle East, North Africa, and parts of Europe, providing essential medicines across various therapeutic areas including cardiology, gastroenterology, and pain management. Pharmel emphasizes high-quality manufacturing standards and aims to improve patient access to affordable healthcare solutions. Their business model encompasses both internal product development and strategic partnerships for distribution and licensing.

Therapeutic areas: CardiovascularNeurologyInfectious DiseasesPulmonologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Pharmel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pharmel.

Explore the full profile